Fate Therapeutics FATE
NASDAQ FATE
$1.61 -0.16 (-9.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Fate Therapeutics (FATE) Capital Expenditures (2012 - 2026)

Updated

Analysis

Fate Therapeutics (FATE) Capital Expenditures (2012 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 3.18 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.36 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 301.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.04 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -3.30 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 587.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 237.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 573.00 Mn
10 Fate Therapeutics 215.18 Mn 76.08 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 80,000.00
Mar 31, 2026 239,000.00
Dec 31, 2025 1.19 Mn
Sep 30, 2025 2.20 Mn
Jun 30, 2025 1.36 Mn
Mar 31, 2025 1.20 Mn
Dec 31, 2024 98,000.00
Sep 30, 2024 495,000.00
Jun 30, 2024 51,000.00
Mar 31, 2024 86,000.00
Dec 31, 2023 181,000.00
Sep 30, 2023 565,000.00
Jun 30, 2023 2.20 Mn
Mar 31, 2023 3.21 Mn
Dec 31, 2022 6.68 Mn
Sep 30, 2022 8.68 Mn
Jun 30, 2022 10.13 Mn
Mar 31, 2022 10.08 Mn
Dec 31, 2021 18.37 Mn
Sep 30, 2021 14.74 Mn
API Access

Fate Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=FATE&period=max&api_key=YOUR_API_KEY